BRAF and cancer: In particular, previous experiments have shown that mutation of the MREs for miR-30a-5p (CDS), miR-182 (CDS), and miR-590 (3′UTR) resulted in reduced ceRNA competition between BRAF and BRAFP1 in cancer cell lines (Karreth et al.